Lv3
228 积分 2024-03-04 加入
JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know
1个月前
已完结
Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)
1个月前
已完结
Editorial: Moving towards prognostic endoscopic scoring in IBD
2个月前
已完结
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
2个月前
已完结
Efficacy and safety of different oral prednisone tapering courses in adult anti‐NMDAR encephalitis: A multicenter prospective cohort study
3个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
3个月前
已完结
Alternative Complement Pathway, Iptacopan, and IgA Nephropathy
4个月前
已完结
Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis
4个月前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
5个月前
已关闭
皖公网安备34019202002308
